ANNX+119.48%20.0%
BHVN-11.27%20.0%
DNLI+60.88%20.0%
KYMR+171.66%20.0%
VRTX+38.70%20.0%
As of Aug 24, 2026, 4:53 AM ET
Rare Diseases '25: CNS/Neuro Constituents
Annexon, Inc.ANNX | 20.0% | -2.12% | -5.06% | -2.87% | -0.49% | 1.00% | -9.46% | 158.67% | -13.92% | -71.08% | 119.48% | $830.7M |
Biohaven Ltd.BHVN | 20.0% | 2.59% | -4.42% | -3.28% | 2.59% | 22.67% | 20.23% | -41.51% | -66.81% | 89.73% | -11.27% | $2.09B |
Denali Therapeutics Inc.DNLI | 20.0% | -0.12% | 0.93% | 7.83% | 8.25% | 50.94% | 17.66% | 81.37% | 0.61% | -51.81% | 60.88% | $3.96B |
Kymera Therapeutics, Inc.KYMR | 20.0% | -1.40% | 9.29% | 8.35% | 15.86% | 53.96% | 31.14% | 354.48% | 150.73% | 116.60% | 171.66% | $9.85B |
Vertex Pharmaceuticals IncorporatedVRTX | 20.0% | 1.44% | 3.47% | 14.81% | 14.87% | 20.89% | 10.31% | 13.35% | 13.88% | 176.23% | 38.70% | $139.10B |
| Theme return | — | 0.08% | 0.84% | 2.72% | 9.63% | 38.52% | 19.68% | 107.99% | 23.98% | 139.11% | 96.36% | — |
| Average | 20.0% | 0.08% | 0.84% | 4.97% | 8.22% | 29.89% | 13.98% | 113.27% | 16.90% | 51.93% | 75.89% | $31.16B |
| Median | 20.0% | -0.12% | 0.93% | 7.83% | 8.25% | 22.67% | 17.66% | 81.37% | 0.61% | 89.73% | 60.88% | $3.96B |
| Std Dev | 0.0% | 1.74% | 5.31% | 7.01% | 6.48% | 19.95% | 13.49% | 137.99% | 72.31% | 96.91% | 63.68% | $54.06B |
| Min | 20.0% | -2.12% | -5.06% | -3.28% | -0.49% | 1.00% | -9.46% | -41.51% | -66.81% | -71.08% | -11.27% | $830.7M |
| Max | 20.0% | 2.59% | 9.29% | 14.81% | 15.86% | 53.96% | 31.14% | 354.48% | 150.73% | 176.23% | 171.66% | $139.10B |
| % Positive Tickers | 40.00% | 60.00% | 60.00% | 80.00% | 100.00% | 80.00% | 80.00% | 60.00% | 60.00% | 80.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Rare Diseases '25: CNS/Neuro tracks 5 publicly listed stocks in this theme: ANNX, BHVN, DNLI, KYMR, VRTX. See the constituent table for details.